Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +118 more
Feb 14, 2020

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathy
  • Birmingham, Alabama
  • +592 more
Dec 4, 2019

Diabetes, Type 2 Trial in United States (Cyclo-Z, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +19 more
Nov 15, 2019

Diabetes, Type 2 Trial in Worldwide (LY2409021, Sitagliptin, Placebo)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +32 more
Sep 25, 2019

Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo, Insulin Glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Fresno, California
  • +39 more
Sep 10, 2019

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +149 more
Jul 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Type 2 Trial in United States (Lyophilized albiglutide DCC pen injector, Lyophilized albiglutide DCC pen injector

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Lyophilized albiglutide DCC pen injector
  • +3 more
  • Birmingham, Alabama
  • +69 more
Jul 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +145 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • basal insulin
  • Birmingham, Alabama
  • +57 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Albuminuria
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +353 more
Nov 19, 2018

Diabetes, Type 2 Trial in United States (ITCA 650 Osmotic Mini Pump 20/60 mcg/day, ITCA 650 Osmotic Mini Pump 60 mcg/day,

Completed
  • Diabetes Mellitus, Type 2
  • ITCA 650 Osmotic Mini Pump 20/60 mcg/day
  • +3 more
  • Birmingham, Alabama
  • +35 more
Nov 1, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Type 2 Trial in Puerto Rico, United States (Insulin glargine, Inhaled Insulin (Exubera))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine
  • Inhaled Insulin (Exubera)
  • Phoenix, Arizona
  • +72 more
Aug 31, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin glargine, 300U/mL, Insulin degludec, 100 U/mL, Non-insulin anti-diabetic treatment)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300U/mL
  • +2 more
  • Sheffield, Alabama
  • +157 more
Aug 14, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Insulin NPH, Diet/exercise)

Terminated
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin detemir
  • +2 more
  • Tucson, Arizona
  • +81 more
Aug 9, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018